Jubilant Radiopharma

Jubilant Radiopharma operates one of the largest radiopharmacy networks in the United States, serving over four million patients annually. The company develops, manufactures, commercializes, and distributes a broad portfolio of diagnostic and therapeutic radiopharmaceuticals for nuclear medicine applications across cardiology, oncology, pulmonology, neurology, renal health, thyroid disorders, and bone diseases. Its products are cGMP compliant and ISO certified. The business consists of two main divisions—Radiopharmaceuticals Division (manufacturing) and Radiopharmacies Division (distribution)—and maintains a strong presence through more than fifty pharmacy locations nationwide. It continues to invest in new product development while supporting clinical research within nuclear medicine.